Company news
Arovella Therapeutics Limited news in 2017
Arovella Therapeutics Limited's news releases, calls and decks from 2017, newest first.
SUDAs Licensee Submits Marketing Application
December 5, 2017
SUDA Acquires Novel Oro-Mucosal Anti-Cancer Agent
November 27, 2017
SUDA Publishes Amended Shareholder Newsletter
September 12, 2017
SUDA Achieves ISO Accreditation
July 30, 2017
Strong Revenue Growth for SUDA Subsidiary
July 23, 2017
SUDA Enters Licence Agreement With Teva
July 4, 2017
SUDA Signs Term Sheet To Acquire Anti-Cancer Agent
June 20, 2017
SUDA Meeting For Zolpimist Into Europe
May 25, 2017
Placement, Interest Shares and Convertible Note Prospectus
April 24, 2017
SUDA Completes $1.5m Capital Raising
April 6, 2017
SUDA Submits Application For ArTiMist
April 3, 2017
SUDA Extends Maturity of Convertible Notes
April 2, 2017
SUDA Enters Feasibility Agreement With Pfizer
March 29, 2017
SUDA expands patent coverage for SUD-003 and SUD-004
March 2, 2017
SUDA Announces Strong Revenue For Westcoast
February 27, 2017
SUDA Update On Discussions with Berlin Pharma
February 26, 2017
Reinstatement to official quotation
February 26, 2017
Suspension from official quotation
January 26, 2017